Toremifene is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. It is antagonistic on mammary and uterine tissue. Licensed in the United States under the brand name Fareston, toremifene is FDA-approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.

Product information

CAS Number: 89778-26-7

Molecular Weight: 405.96

Formula: C26H28ClNO

Chemical Name: (2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine

Smiles: CN(C)CCOC1C=CC(=CC=1)/C(=C(/CCCl)\C1C=CC=CC=1)/C1C=CC=CC=1

InChiKey: XFCLJVABOIYOMF-QPLCGJKRSA-N

InChi: InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥360 days if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.